These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 23141847

  • 1. Gender differences of bleeding and stroke risk in very old atrial fibrillation patients on VKA treatment: results of the EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).
    Poli D, Antonucci E, Testa S, Ageno W, Palareti G, FCSA (Italian Federation of Anticoagulation Clinics).
    Thromb Res; 2013 Jan; 131(1):12-6. PubMed ID: 23141847
    [Abstract] [Full Text] [Related]

  • 2. Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).
    Poli D, Antonucci E, Zanazzi M, Grifoni E, Testa S, Ageno W, Palareti G.
    Thromb Haemost; 2012 Jun; 107(6):1100-6. PubMed ID: 22535516
    [Abstract] [Full Text] [Related]

  • 3. Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation.
    Poli D, Antonucci E, Testa S, Tosetto A, Ageno W, Palareti G, Italian Federation of Anticoagulation Clinics.
    Circulation; 2011 Aug 16; 124(7):824-9. PubMed ID: 21810658
    [Abstract] [Full Text] [Related]

  • 4. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment.
    Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D.
    Thromb Haemost; 2009 May 16; 101(5):938-42. PubMed ID: 19404548
    [Abstract] [Full Text] [Related]

  • 5. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S, Olesen JB, Clémenty N, Lagrenade I, Babuty D, Lip GY, Fauchier L.
    J Cardiovasc Electrophysiol; 2012 Jul 16; 23(7):708-13. PubMed ID: 22268375
    [Abstract] [Full Text] [Related]

  • 6. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
    Gallego P, Roldán V, Torregrosa JM, Gálvez J, Valdés M, Vicente V, Marín F, Lip GY.
    Circ Arrhythm Electrophysiol; 2012 Apr 16; 5(2):312-8. PubMed ID: 22319005
    [Abstract] [Full Text] [Related]

  • 7. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.
    Am J Geriatr Pharmacother; 2009 Jun 16; 7(3):159-66. PubMed ID: 19616184
    [Abstract] [Full Text] [Related]

  • 8. Stroke and major bleeding risk in elderly patients aged ≥75 years with atrial fibrillation: the Loire Valley atrial fibrillation project.
    Lip GY, Clementy N, Pericart L, Banerjee A, Fauchier L.
    Stroke; 2015 Jan 16; 46(1):143-50. PubMed ID: 25424474
    [Abstract] [Full Text] [Related]

  • 9. Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study.
    Pengo V, Legnani C, Noventa F, Palareti G, ISCOAT Study Group.(Italian Study on Complications of Oral Anticoagulant Therapy).
    Thromb Haemost; 2001 Mar 16; 85(3):418-22. PubMed ID: 11307807
    [Abstract] [Full Text] [Related]

  • 10. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S, Bennett D, Smith DJ.
    Am J Cardiovasc Drugs; 2010 Mar 16; 10(1):37-48. PubMed ID: 20104933
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
    Friberg L, Rosenqvist M, Lip GY.
    Eur Heart J; 2012 Jun 16; 33(12):1500-10. PubMed ID: 22246443
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Risk of falls and major bleeds in patients on oral anticoagulation therapy.
    Donzé J, Clair C, Hug B, Rodondi N, Waeber G, Cornuz J, Aujesky D.
    Am J Med; 2012 Aug 16; 125(8):773-8. PubMed ID: 22840664
    [Abstract] [Full Text] [Related]

  • 14. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score.
    Lip GY, Frison L, Halperin JL, Lane DA.
    J Am Coll Cardiol; 2011 Jan 11; 57(2):173-80. PubMed ID: 21111555
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation.
    Gallego P, Roldan V, Marín F, Romera M, Valdés M, Vicente V, Lip GY.
    Thromb Haemost; 2013 Dec 11; 110(6):1189-98. PubMed ID: 24096615
    [Abstract] [Full Text] [Related]

  • 17. Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation.
    Tincani E, Baldini P, Crowther MA, Zanasi A, Ferrari P, Cenci AM, Rioli G.
    Blood Coagul Fibrinolysis; 2009 Jan 11; 20(1):47-51. PubMed ID: 20523164
    [Abstract] [Full Text] [Related]

  • 18. The safety and efficacy of vitamin K antagonist in patients with atrial fibrillation and liver cirrhosis.
    Lee SJ, Uhm JS, Kim JY, Pak HN, Lee MH, Joung B.
    Int J Cardiol; 2015 Feb 01; 180():185-91. PubMed ID: 25463361
    [Abstract] [Full Text] [Related]

  • 19. Assessing the risk of bleeding in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation project.
    Lip GY, Banerjee A, Lagrenade I, Lane DA, Taillandier S, Fauchier L.
    Circ Arrhythm Electrophysiol; 2012 Oct 01; 5(5):941-8. PubMed ID: 22923275
    [Abstract] [Full Text] [Related]

  • 20. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP, Flaker G, Waldo AL, Corley SD, Greene HL, Safford RE, Rosenfeld LE, Mitrani G, Nemeth M, AFFIRM Investigators.
    Am Heart J; 2005 Apr 01; 149(4):650-6. PubMed ID: 15990748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.